Claims & Labels

Canada NHP labelling changes: what to update now and what can wait

Canada NHP labelling changes: what to update now and what can wait

Canada NHP labelling changes: what to update now and what can wait

Sources checked 16 November 2026

Plan Canadian NHP label updates with a clear guide to the 2028 deadline, proposed changes, monograph updates and practical artwork reviews.

Plan Canadian NHP label updates with a clear guide to the 2028 deadline, proposed changes, monograph updates and practical artwork reviews.

The short answer

Start by separating safety-directed changes, existing compliance gaps and monograph-related updates. Health Canada has announced flexibility for certain monograph updates and plans to propose a transition beyond June 2028. The replacement timeline is not yet final. Use the extra planning space to audit your labels and control artwork changes.

Who this article is for

Canadian NHP licence holders, international brands entering Canada, private-label businesses and teams managing several packaging versions.

Key takeaways

  • Separate mandatory safety changes from eligible monograph updates.

  • Plan inventory and artwork together.

  • Keep a documented decision for every deferred change.

A practical label planning guide for brands balancing regulatory changes, packaging inventory and the cost of redesigning twice.

What is changing, and what is still proposed?

Health Canada’s labelling guidance gives June 22, 2028 as the compliance date under the existing transition and exemption arrangements. Bulletin 10 announces plans for more flexible rules and a proposed transition beyond June 2028, with draft amendments targeted for spring 2027. That planned extension does not yet establish a replacement date.


Which label changes should you address now?

Bulletin 13, issued October 13, 2026, says monograph-related label updates need not be implemented until the end of the forthcoming regulatory transition period. Health Canada-directed safety changes remain mandatory on their specified timelines. Existing compliance gaps still need assessment. The table below is our practical triage framework.


Situation

Practical response

Record to keep

Health Canada directs a safety update

Follow the specified deadline and assess affected stock.

Notice, implementation plan and completion evidence.

Artwork differs from the authorized product

Assess the discrepancy and the appropriate correction or submission.

Licence-to-label comparison and regulatory decision.

Update arises from a revised monograph

Assess eligibility for the interim approach and document the plan.

Monograph version, change summary and rationale.

Redesign is mainly for the coming format changes

Build a flexible layout; review proposals before a large print commitment.

Artwork assumptions and decision checkpoint.

Commercial rebrand or new pack size

Combine planned changes after a technical review.

Approved master copy and version history.

How to audit an NHP label before redesigning it

Build a master copy document before asking a designer to adjust a crowded panel. Include the product identity, ingredient declarations, directions, risk information and required business details. Compare that master against the licence and the applicable labelling requirements, then compare the actual artwork against the master. This makes missing text and inconsistent versions much easier to identify.


For bilingual packs, review both languages as one controlled record. A late translation can change line breaks, panel space and the readability of warnings. Review the smallest marketed pack first because it usually reveals the toughest layout constraints.


How to avoid paying for two packaging overhauls

Create a SKU register that connects each artwork version to its remaining stock, print quantity and next production run. A low-volume SKU with a large label inventory may need a different purchasing decision from a fast-moving product that will be reprinted next month. Keep regulatory due dates separate from commercial preferences in the register.


Before ordering a long packaging run, ask what information could change before those labels are used. Consider a smaller order, a flexible carton layout or coordinated artwork work where commercially sensible. Any approach involving existing stock still needs a product-specific compliance assessment; unused inventory alone does not justify continued use of an incorrect label.


Worked planning example: one brand, three different decisions

Imagine a brand with a capsule product receiving a safety-directed update, a powder affected by a routine monograph revision and a third product scheduled for a visual rebrand. Treating all three as one redesign project could delay the urgent change or create unnecessary rework.


Our suggested approach is to give the safety change its own implementation track, assess the powder against the interim bulletin and hold the rebrand’s final print approval until its technical copy is settled. Assign a decision owner and a review date for each. This is an illustrative planning example, not a statement that any particular product qualifies for deferral.


What should a useful label review deliver?

A useful review leaves the brand with instructions that a designer can implement: marked-up artwork, approved wording, a list of unresolved questions and a version-controlled decision log. It should distinguish required corrections from optional editorial improvements.


Ask for a clear handoff between the regulatory reviewer, translator, designer and person approving the print proof. Record who checks the final file after changes are made. A technically correct comment has little value if the wrong artwork revision reaches the printer.


What to prepare

  • Current product licence and any amendments

  • Marketed label PDFs for every bottle, carton and pack size

  • Proposed artwork and English/French copy

  • Relevant monographs and any Health Canada correspondence

  • Inventory quantities, print lead times and planned production dates

  • Marketplace listings and other consumer-facing claims

Frequently asked

Has the June 2028 deadline already been replaced?

A later transition is planned for proposed amendments. Do not assume a specific replacement date until the regulatory process establishes it. Check the latest Health Canada bulletin before making a print decision.

Can we defer a safety warning change?

The interim monograph flexibility does not cover safety changes directed by Health Canada. Follow the timeline in the applicable notice or direction.

Should we stop all label redesign work?

No. Complete your licence-to-label audit, master copy and inventory planning now. Separate those useful tasks from final print decisions that depend on future requirements.

Can a designer alone complete the review?

Design expertise helps with layout and readability. Technical copy, licence alignment and regulatory decisions also need appropriate review. Define those responsibilities before artwork begins.

Can Kompete review one product or a full catalogue?

The scope can be organized around a single SKU or a portfolio. Share the labels, licences and intended changes so the review can be scoped around the decisions you need.

Next step

Bring your specifics to a conversation.

Bring your specifics to a conversation.

Bring your specifics to a conversation.

General guidance only goes so far. Send us the formula, the label, the request or the market, and we will tell you what we would do next.

Request an NHP label review